XML 107 R30.htm IDEA: XBRL DOCUMENT
v3.26.1

Contract liabilities | 12 Months Ended
--- | ---
Dec. 31, 2025
Contract liabilities [abstract] |
Contract liabilities | Revenue The Group derives its revenue from contracts with customers for the transfer of goods and services at a point in time and over time in the following major product lines. Following the classification of Diagnostics - sale of precision oncology services as a discontinued operation during the year ended December 31, 2025, the following disclosure of revenue has been retrospectively recast to represent results from continuing operations. The disclosure of revenue by product line is consistent with the revenue information that is disclosed for each reportable segment under IFRS 8 Operating Segments ("IFRS 8") (see note 6). Disaggregation of revenue
| 2025 |  | 2024 |  | 2023
|  |  | (Restated) |  | (Restated)
Continuing operations |  |  |  |  |
External revenue by product line |  |  |  |  |
Prevention - genetic testing | $ | 12,945 |  |  | $ | 10,367 |  |  | $ | 6,155 |
Consumer health - health and wellness solutions | 60,149 |  |  | 370 |  |  | — |
Consumer health - sports distribution | 19,296 |  |  | 5,199 |  |  | — |
| $ | 92,390 |  |  | $ | 15,936 |  |  | $ | 6,155 |
| 2025 |  | 2024 |  | 2023
|  |  | (Restated) |  | (Restated)
Continuing operations |  |  |  |  |
External revenue by timing of revenue |  |  |  |  |
Goods transferred at a point in time | $ | 78,737 |  |  | $ | 5,413 |  |  | $ | — |
Services transferred at a point in time | 12,945 |  |  | 10,367 |  |  | 6,155 |
Services transferred overtime | 708 |  |  | 156 |  |  | — |
| $ | 92,390 |  |  | $ | 15,936 |  |  | $ | 6,155 |
Revenue expected to be recognized in the future arising from contracts with customers in existence at the report date At December 31, 2025, 2024 and 2023, the amount of service fee income allocated to the remaining performance obligations under the Group’s existing contracts that are non-refundable is $3,086, $6,491 and $6,111, respectively. The Group will recognize the expected revenue in the future when the performance obligations are fulfilled, which may be after one year from the end of the reporting period. Such amount does not include any variable consideration. Contract liabilities Contract liabilities represent non-refundable consideration received from customers before the Group recognizes the related revenue. Such consideration is recognized as contract liabilities until the performance obligation is fulfilled or the likelihood of having to fulfil the performance obligation is remote and it is highly probable that a significant reversal of revenue will not occur.
| 2025 |  | 2024
Contract liabilities | $ | 3,086 |  |  | $ | 6,491 |
Movement in contract liabilities is as follows:
| 2025 |  | 2024
Balance at January 1 | $ | 6,491 |  |  | $ | 6,111 |
Revenue recognized (Note) | (71,733) |  |  | (9,089) |
Receipt from customers upon entering sales contracts | 68,391 |  |  | 9,469 |
Eliminated on disposal of a subsidiary | (63) |  |  | — |
Balance at December 31 | $ | 3,086 |  |  | $ | 6,491 |
Note: At December 31, 2025 and 2024, the amount of $4,832 and $1,126, respectively, recognized as revenue from the expiration of unused test kits, which had previously been recorded as contract liabilities. At December 31, 2025 and 2024, the amount of $2,220 and $2,757, respectively, are expected to be recognized as revenue within one year.

X
- References No definition available. + Details
Name: | ifrs-full_ContractLiabilitiesAbstract
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for revenue from contracts with customers. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2025-01-01 -Section Presentation -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 15 -IssueDate 2025-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration